Dornase Alfa - CISMeF

Preferred Label : Dornase Alfa;

NCIt synonyms : Recombinant Human Deoxyribonuclease I;

NCIt definition : A recombinant human deoxyribonuclease I (rhDNAse) with selective DNA cleaving activity. Upon intrapleural administration, dornase alfa catalyzes the degradation of extracellular DNA in airway secretions, which can reduce their viscosity. Thus, dornase alfa may both promote the clearing of airway mucus and improve pulmonary function.;

UNII : 953A26OA1Y;

CAS number : 143831-71-4;

Drug name : Pulmozyme;

Détails

Origin ID

C81664;

UMLS CUI

C1135662;

See also inter- (CISMeF)
- DNASE1 protein, human [MeSH Supplementary Concept]
- Product containing dornase alfa (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Enzyme [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Dornase alfa (substance) [SNOMED CT concept]
- Product containing dornase alfa (medicinal product) [SNOMED CT concept]
- dornase alfa [MeSH Supplementary Concept]
- dornase alfa [MeSH concept]
- dornase alfa (desoxyribonuclease) [ATC Code]
Validated automatic mappings to BTNT
- dornase alfa (desoxyribonuclease) [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients